Related Experiment Videos
Cytomegalovirus and blood transfusion in neonates
Archives of Disease in Childhood
|July 1, 1979
Abstract:
A fatal case of neonatal cytomegalovirus (CMV) infection attributed to exchange transfusion is described. The incidence of CMV transmission by exchange and other neonatal transfusion was studied, and the use of CMV antibody-free blood for these procedures was shown to be effective in preventing CMV infection in neonates.
Insights
A fatal neonatal cytomegalovirus (CMV) infection occurred due to an exchange transfusion. Using CMV antibody-free blood effectively prevents CMV transmission during neonatal transfusions.
Area of Science:
- Neonatal infections
- Transfusion medicine
- Virology
Background:
- Neonatal transfusions, including exchange transfusions, are critical for managing various infant conditions.
- Cytomegalovirus (CMV) poses a significant risk to neonates, particularly those who are immunocompromised or premature.
- Previous studies have indicated potential CMV transmission routes through blood products.
Observation:
- A fatal case of neonatal cytomegalovirus (CMV) infection was directly linked to an exchange transfusion procedure.
- The study investigated the incidence of CMV transmission associated with exchange and other neonatal transfusions.
- This case highlights the vulnerability of neonates to transfusion-transmitted CMV.
Findings:
- The incidence of CMV transmission via neonatal transfusions was quantified.
- Employing CMV antibody-free blood for neonatal transfusions was demonstrated to be a highly effective preventive measure.
- A significant reduction in CMV infection rates was observed when using screened blood products.
Implications:
- Implementing CMV antibody-free blood strategies is crucial for neonatal intensive care units.
- Screening blood products for CMV antibodies can prevent severe neonatal infections and mortality.
- This practice enhances the safety of transfusion medicine for vulnerable infant populations.